• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

作者信息

Pende Daniela, Rivera Paola, Marcenaro Stefania, Chang Chien-Chung, Biassoni Roberto, Conte Romana, Kubin Marek, Cosman David, Ferrone Soldano, Moretta Lorenzo, Moretta Alessandro

机构信息

Istituto Nazionale per la Ricerca sul Cancro, 16132 Genova, Italy.

出版信息

Cancer Res. 2002 Nov 1;62(21):6178-86.

PMID:12414645
Abstract

NKG2D, together with NKp46 and NKp30, represents a major triggering receptor involved in the induction of cytotoxicity by both resting and activated human natural killer cells. In this study, we analyzed the expression and the functional relevance of MHC class I-related chain A (MICA) and UL16 binding protein (ULBP), the major cellular ligands for human NKG2D, in human tumor cell lines of different histological origin. We show that MICA and ULBP are frequently coexpressed by carcinoma cell lines, whereas MICA is expressed more frequently than ULBP by melanoma cell lines. Interestingly, the MICA(-) ULBP(+) phenotype was detected in most T cell leukemia cell lines, whereas the MICA(-) ULBP(-) phenotype characterized all acute myeloid leukemia and most B-cell lymphoma cell lines analyzed. These results, together with functional experiments, based on monoclonal antibody-mediated blocking of either NKG2D or its ligands, showed that killing of certain MICA(-) cell tumors is at least in part NKG2D dependent. Indeed, leukemic T cells as well as certain B-cell lymphomas were killed in a NKG2D-dependent fashion upon recognition of ULBP molecules. Moreover, ULBP could induce NKG2D-mediated NK cell triggering also in tumors coexpressing MICA. Our data suggest that the involvement of NKG2D in natural killer cell-mediated cytotoxicity strictly correlates with the expression and the surface density of MICA and ULBP on target cell tumors of different histotypes.

摘要

NKG2D与NKp46和NKp30一起,是静息和活化的人自然杀伤细胞诱导细胞毒性所涉及的主要触发受体。在本研究中,我们分析了人NKG2D的主要细胞配体——MHC I类相关链A(MICA)和UL16结合蛋白(ULBP)在不同组织学来源的人肿瘤细胞系中的表达及其功能相关性。我们发现,癌细胞系经常共表达MICA和ULBP,而黑色素瘤细胞系中MICA的表达比ULBP更频繁。有趣的是,在大多数T细胞白血病细胞系中检测到MICA(-) ULBP(+)表型,而MICA(-) ULBP(-)表型则是所有分析的急性髓细胞白血病和大多数B细胞淋巴瘤细胞系的特征。这些结果与基于单克隆抗体介导的对NKG2D或其配体的阻断的功能实验一起表明,某些MICA(-)细胞肿瘤的杀伤至少部分依赖于NKG2D。事实上,白血病T细胞以及某些B细胞淋巴瘤在识别ULBP分子后以NKG2D依赖的方式被杀伤。此外,ULBP在共表达MICA的肿瘤中也能诱导NKG2D介导的NK细胞触发。我们的数据表明,NKG2D参与自然杀伤细胞介导的细胞毒性与不同组织类型的靶细胞肿瘤上MICA和ULBP的表达及表面密度密切相关。

相似文献

1
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.
2
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.可溶性ULBP通过下调NKG2D表达来抑制自然杀伤细胞活性。
Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21.
3
Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.树突状细胞上自然杀伤细胞2D配体UL16结合蛋白-1(ULBP-1)的表达。
Eur J Immunol. 2006 Jan;36(1):65-72. doi: 10.1002/eji.200535115.
4
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.人γδT细胞对多种上皮肿瘤细胞的裂解作用:NKG2D配体的参与以及T细胞受体与NKG2D依赖性识别
Scand J Immunol. 2007 Aug-Sep;66(2-3):320-8. doi: 10.1111/j.1365-3083.2007.01963.x.
5
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.转化生长因子-β和金属蛋白酶对恶性胶质瘤细胞表面NKG2D配体的表达有不同程度的抑制作用。
Brain. 2006 Sep;129(Pt 9):2416-25. doi: 10.1093/brain/awl205. Epub 2006 Aug 3.
6
Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.应激诱导蛋白ULBP和MICA的细胞表面组织,其通过NKG2D刺激人自然杀伤细胞和T细胞。
J Exp Med. 2004 Apr 5;199(7):1005-10. doi: 10.1084/jem.20032194. Epub 2004 Mar 29.
7
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.组蛋白去乙酰化酶抑制剂丙戊酸钠通过特异性诱导NKG2D配体介导自然杀伤细胞对肝癌细胞的杀伤作用。
Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252.
8
NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.NKG2D和自然细胞毒性受体参与自然杀伤细胞与自身抗原呈递细胞和基质细胞的相互作用。
Ann N Y Acad Sci. 2007 Aug;1109:47-57. doi: 10.1196/annals.1398.007.
9
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.作为人类神经母细胞瘤免疫逃逸策略的NKG2D配体下调和/或释放
Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316.
10
Proteolytic release of soluble UL16-binding protein 2 from tumor cells.肿瘤细胞中可溶性UL16结合蛋白2的蛋白水解释放。
Cancer Res. 2006 Mar 1;66(5):2520-6. doi: 10.1158/0008-5472.CAN-05-2520.

引用本文的文献

1
Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.原始细胞弥合先天免疫与适应性免疫之间的差距。
Adv Exp Med Biol. 2025;1476:47-82. doi: 10.1007/978-3-031-85340-1_3.
2
Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8 T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model.在小鼠肿瘤模型的T细胞调节条件下,异位ULBP2与CD8 T细胞中NKG2D表达降低有关。
Cells. 2025 Jun 13;14(12):893. doi: 10.3390/cells14120893.
3
ULBP2 Promotes Tumor Progression by Suppressing NKG2D-Mediated Anti-Tumor Immunity.
ULBP2通过抑制NKG2D介导的抗肿瘤免疫促进肿瘤进展。
Int J Mol Sci. 2025 Mar 24;26(7):2950. doi: 10.3390/ijms26072950.
4
Human decidua basalis mesenchymal stem/stromal cells enhance anticancer properties of human natural killer cells, .人蜕膜基底层间充质干/基质细胞增强人自然杀伤细胞的抗癌特性。
Front Cell Dev Biol. 2024 Oct 30;12:1435484. doi: 10.3389/fcell.2024.1435484. eCollection 2024.
5
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer.嵌合抗原受体 T 细胞免疫疗法治疗卵巢癌:让沉默的杀手安静下来。
Front Immunol. 2023 Dec 7;14:1302307. doi: 10.3389/fimmu.2023.1302307. eCollection 2023.
6
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma.可溶性MICA/可溶性MICB对新诊断弥漫性大B细胞淋巴瘤免疫化疗疗效的影响。
Front Oncol. 2023 Nov 16;13:1194315. doi: 10.3389/fonc.2023.1194315. eCollection 2023.
7
Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34 progenitor cell-derived NK cells.早期TRAIL参与可引发CD34祖细胞衍生的自然杀伤细胞对黑色素瘤的有效多模态靶向作用。
iScience. 2023 Jun 9;26(7):107078. doi: 10.1016/j.isci.2023.107078. eCollection 2023 Jul 21.
8
Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer.DKK1 抑制与 NKG2D 嵌合抗原受体 T 细胞联合治疗胃癌。
Cancer Sci. 2023 Jul;114(7):2798-2809. doi: 10.1111/cas.15828. Epub 2023 May 7.
9
The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies.自然杀伤细胞在EB病毒感染及相关疾病中的作用:当前认识与新型治疗策略提示
Cancers (Basel). 2023 Mar 22;15(6):1914. doi: 10.3390/cancers15061914.
10
miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction.miR-221-5p 和 miR-186-5p 是自然杀伤细胞功能障碍中膀胱癌来源外泌体 miRNA 的关键。
Int J Mol Sci. 2022 Dec 2;23(23):15177. doi: 10.3390/ijms232315177.